Generali Investments Cee, Investicni Spolecnost, A.S. Biogen Inc. Transaction History
Generali Investments Cee, Investicni Spolecnost, A.S.
- $1.22 Trillion
- Q2 2025
A detailed history of Generali Investments Cee, Investicni Spolecnost, A.S. transactions in Biogen Inc. stock. As of the latest transaction made, Generali Investments Cee, Investicni Spolecnost, A.S. holds 38,755 shares of BIIB stock, worth $5.61 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
38,755
Previous 27,060
43.22%
Holding current value
$5.61 Million
Previous $3.7 Billion
31.44%
% of portfolio
0.4%
Previous 0.35%
Shares
2 transactions
Others Institutions Holding BIIB
# of Institutions
1,018Shares Held
131MCall Options Held
2.87MPut Options Held
2.57M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.5 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.29 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.11 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$1.08 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$695 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.9B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...